World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages

about

Prognostic Significance of Epidermal Growth Factor Receptor in Patients of Glioblastoma Multiforme.Whole-exome sequencing identifies germline mutation in TP53 and ATRX in a child with genomically aberrant AT/RT and her mother with anaplastic astrocytoma.

P2860

Q42046941-6E56C064-5BAD-4CBB-A987-B2D9FB855104 Q54958675-9EA59FE4-1C1A-4ECD-98E5-6E148D5DCD73

P2860

World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages

Item

http://www.wikidata.org/entity/Q37170743

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

World Health Organization grad ...... ically distinct tumor lineages

@en

World Health Organization grad ...... cally distinct tumor lineages.

@nl

type

Item

label

World Health Organization grad ...... ically distinct tumor lineages

@en

World Health Organization grad ...... cally distinct tumor lineages.

@nl

prefLabel

World Health Organization grad ...... ically distinct tumor lineages

@en

World Health Organization grad ...... cally distinct tumor lineages.

@nl

P1476

World Health Organization grad ...... ically distinct tumor lineages

@en

P2093

Hikaru Sasaki

http://www.w3.org/2001/XMLSchema#string

Masato Abe

http://www.w3.org/2001/XMLSchema#string

Mitsuhiro Hasegawa

http://www.w3.org/2001/XMLSchema#string

Natsuki Hattori

http://www.w3.org/2001/XMLSchema#string

Saeko Hayashi

http://www.w3.org/2001/XMLSchema#string

Shigeo Ohba

http://www.w3.org/2001/XMLSchema#string

Shunsuke Nakae

http://www.w3.org/2001/XMLSchema#string

Takuro Hayashi

http://www.w3.org/2001/XMLSchema#string

Yuichi Hirose

http://www.w3.org/2001/XMLSchema#string

Yuya Nishiyama

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

The 2007 WHO classification of tumours of the central nervous system

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective

Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study.

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

Recent surgical management of gliomas.

Molecular classification of low-grade diffuse gliomas.

Histological grading of gliomas.

P304

1159-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12969

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Kazuhide Adachi

P577

2016-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27196377

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

P932

4982592

http://www.w3.org/2001/XMLSchema#string

World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages

about

P2860

P2860

World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932